SFP1 Softmatic AG

DGAP-News: AlzChem Group AG: CEO Ulli Seibel leaves the company at the end of 2019 after ten successful years

DGAP-News: AlzChem Group AG / Key word(s): Personnel
AlzChem Group AG: CEO Ulli Seibel leaves the company at the end of 2019 after ten successful years

03.04.2019 / 15:51
The issuer is solely responsible for the content of this announcement.


AlzChem Group AG: CEO Ulli Seibel leaves the company at the end of 2019 after ten successful years

Trostberg, April 3, 2019 - Ulli Seibel, CEO of AlzChem Group AG, informed the Supervisory Board today that he will leave the company on December 31, 2019 for personal reasons.

Markus Zöllner, Chairman of the Supervisory Board: "In recent years, Mr. Seibel has been instrumental in driving the realignment of AlzChem into a specialty chemicals company, including the associated investment program. We would like to express our sincere thanks to him for this. We therefore regret all the more Mr. Seibel's resignation at the end of the year."

Ulli Seibel: "After ten exciting and successful years at the helm of AlzChem, it is time for me to pass on the baton. I will continue to be fully committed until the end of the year and ensure a smooth transition so that AlzChem Group AG can continue its growth course without interruption."

About AlzChem
AlzChem Group AG is a vertically integrated manufacturer of various chemical products based on the NCN chain. These are products with typical nitrogen-carbon-nitrogen bonding that are used in a wide variety of different industries. The company has a leading position in select niche markets. The strategic focus of growth and the main focus of its extensive research and development are on the business segment Specialty Chemicals. The company has around 1,560 employees at four sites in Germany and three other sites abroad.



03.04.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


Language: English
Company: AlzChem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany
Phone:
Fax:
E-mail:
Internet:
ISIN: DE000A0AHT46
WKN: A0AHT4
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart
EQS News ID: 795453

 
End of News DGAP News Service

795453  03.04.2019 

fncls.ssp?fn=show_t_gif&application_id=795453&application_name=news&site_id=research_pool
EN
03/04/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Softmatic AG

 PRESS RELEASE

DGAP-News: AlzChem Group AG: Andreas Niedermaier wird neuer CEO - Dr. ...

DGAP-News: AlzChem Group AG / Schlagwort(e): Personalie AlzChem Group AG: Andreas Niedermaier wird neuer CEO - Dr. Georg Weichselbaumer zum 1. Juli 2019 in den Vorstand berufen 03.06.2019 / 09:00 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. AlzChem Group AG: Andreas Niedermaier wird neuer CEO - Dr. Georg Weichselbaumer zum 1. Juli 2019 in den Vorstand berufen Trostberg, 3. Juni 2019 - Der Aufsichtsrat der AlzChem Group AG hat mit Blick auf das Ausscheiden des derzeitigen Vorstandsvorsitzenden (CEO), Herrn Ulli Seibel, zum 31. Dezember 2019 beschlossen,...

 PRESS RELEASE

DGAP-News: AlzChem Group AG: Andreas Niedermaier becomes new CEO - Dr....

DGAP-News: AlzChem Group AG / Key word(s): Personnel AlzChem Group AG: Andreas Niedermaier becomes new CEO - Dr. Georg Weichselbaumer appointed to the Management Board effective July 1, 2019 03.06.2019 / 09:00 The issuer is solely responsible for the content of this announcement. AlzChem Group AG: Andreas Niedermaier becomes new CEO - Dr. Georg Weichselbaumer appointed to the Management Board effective July 1, 2019 Trostberg, June 3, 2019 - The Supervisory Board of AlzChem Group AG has decided to appoint Mr. Andreas Niedermaier (CFO) as the new CEO with effect from July 1, 2019, in view...

 PRESS RELEASE

DGAP-News: AlzChem Group AG: Annual General Meeting approves dividend ...

DGAP-News: AlzChem Group AG / Key word(s): AGM/EGM AlzChem Group AG: Annual General Meeting approves dividend of EUR 0.09 per share 14.05.2019 / 13:55 The issuer is solely responsible for the content of this announcement. AlzChem Group AG: Annual General Meeting approves dividend of EUR 0.09 per share Trostberg, May 14, 2019 - At today's Annual General Meeting of AlzChem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, the shareholders present honored the successful business development and corporate strategy and e...

 PRESS RELEASE

DGAP-News: AlzChem Group AG: Hauptversammlung beschließt Dividende in...

DGAP-News: AlzChem Group AG / Schlagwort(e): Hauptversammlung AlzChem Group AG: Hauptversammlung beschließt Dividende in Höhe von 0,09 Euro je Aktie 14.05.2019 / 13:55 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. AlzChem Group AG: Hauptversammlung beschließt Dividende in Höhe von 0,09 Euro je Aktie Trostberg, 14. Mai 2019 - Auf der heutigen Hauptversammlung der AlzChem Group AG, eines vertikal integrierten Spezialchemie-Anbieters mit führender Marktposition in ausgewählten Nischenmärkten, honorierten die anwesenden Aktionärinnen und Aktionäre d...

 PRESS RELEASE

DGAP-News: AlzChem Group AG with planned sales and earnings developmen...

DGAP-News: AlzChem Group AG / Key word(s): Quarterly / Interim Statement AlzChem Group AG with planned sales and earnings development in the first quarter of 2019 10.05.2019 / 06:30 The issuer is solely responsible for the content of this announcement. AlzChem Group AG with planned sales and earnings development in the first quarter of 2019 Positive market feedback on own distribution of Creamino Full-year forecast with sales growth and stable earnings confirmed Trostberg, May 10, 2019 - AlzChem Group AG, a vertically integrated specialty chemicals supplier with a leading market posi...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch